Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Vertex Pharmaceuticals (Sweden) AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 5,982 Less Arrow 5,249 Less Arrow 4,638
Financial expenses 0 More Arrow 30 Less Arrow 10
Earnings before taxes 427 Less Arrow 345 Less Arrow 311
EBITDA 434 Less Arrow 415 Less Arrow 323
Total assets 3,172 Less Arrow 2,939 More Arrow 5,889
Current assets 3,165 Less Arrow 2,915 More Arrow 5,819
Current liabilities 1,419 More Arrow 1,464 More Arrow 4,673
Equity capital 1,752 Less Arrow 1,474 Less Arrow 1,216
- share capital 4 More Arrow 5 Less Arrow 4
Employees (average) 11 Less Arrow 9 Less Arrow 7

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 55.2% Less Arrow 50.2% Less Arrow 20.6%
Turnover per employee 544 More Arrow 583 More Arrow 663
Profit as a percentage of turnover 7.1% Less Arrow 6.6% More Arrow 6.7%
Return on assets (ROA) 13.5% Less Arrow 12.8% Less Arrow 5.5%
Current ratio 223.0% Less Arrow 199.1% Less Arrow 124.5%
Return on equity (ROE) 24.4% Less Arrow 23.4% More Arrow 25.6%
Change turnover 912 Less Arrow 597 Less Arrow 583
Change turnover % 18% Less Arrow 13% More Arrow 14%
Chg. No. of employees 2 Equal arrow 2 Less Arrow 0
Chg. No. of employees % 22% More Arrow 29% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.